MTEX vs. IMCC, BGXX, NAII, UPHL, PLAG, COCP, BIMI, TLPH, DOMH, and KPRX
Should you be buying Mannatech stock or one of its competitors? The main competitors of Mannatech include IM Cannabis (IMCC), Bright Green (BGXX), Natural Alternatives International (NAII), UpHealth (UPHL), Planet Green (PLAG), Cocrystal Pharma (COCP), BIMI (BIMI), Talphera (TLPH), Dominari (DOMH), and Kiora Pharmaceuticals (KPRX). These companies are all part of the "medical" sector.
Mannatech (NASDAQ:MTEX) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, community ranking, dividends, profitability and media sentiment.
13.0% of Mannatech shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 53.1% of Mannatech shares are held by insiders. Comparatively, 5.9% of IM Cannabis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Mannatech has higher revenue and earnings than IM Cannabis. Mannatech is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks.
Mannatech has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500.
Mannatech received 274 more outperform votes than IM Cannabis when rated by MarketBeat users. Likewise, 74.67% of users gave Mannatech an outperform vote while only 42.86% of users gave IM Cannabis an outperform vote.
Mannatech has a net margin of -1.70% compared to IM Cannabis' net margin of -16.42%. Mannatech's return on equity of -19.19% beat IM Cannabis' return on equity.
In the previous week, Mannatech had 4 more articles in the media than IM Cannabis. MarketBeat recorded 5 mentions for Mannatech and 1 mentions for IM Cannabis. Mannatech's average media sentiment score of 0.43 beat IM Cannabis' score of -1.00 indicating that Mannatech is being referred to more favorably in the media.
Summary
Mannatech beats IM Cannabis on 12 of the 15 factors compared between the two stocks.
Get Mannatech News Delivered to You Automatically
Sign up to receive the latest news and ratings for MTEX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mannatech Competitors List
Related Companies and Tools
